Dashboard
Manage Tickers

RVPH REVIVA PHARMACEUTICALS HOLD...

Nasdaq revivapharma.com


$ 0.50 $ -0.04 (-7.19 %)    

Friday, 14-Nov-2025 15:54:59 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 0.5022
$ 0.52
$ 0.50 x 1,000
$ 0.51 x 700
$ 0.50 - $ 0.53
$ 0.25 - $ 4.28
3,829,139
na
57.78M
$ 0.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 04-02-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 04-15-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-15-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 05-17-2021 03-31-2021 10-Q
20 03-22-2021 12-31-2020 10-K
21 01-14-2021 11-30-2020 10-Q
22 10-14-2020 08-31-2020 10-Q
23 07-07-2020 05-31-2020 10-Q
24 05-04-2020 02-29-2020 10-K
25 01-10-2020 11-30-2019 10-Q
26 10-08-2019 08-31-2019 10-Q
27 07-03-2019 05-31-2019 10-Q
28 05-22-2019 02-28-2019 10-K
29 01-09-2019 11-30-2018 10-Q
30 10-11-2018 08-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reviva-pharmaceuticals-q3-eps-006-beats-010-estimate
Reviva Pharmaceuticals Q3 EPS $(0.06) Beat...
11/13/2025 21:34:55

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate o...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
11/13/2025 21:06:42

reviva-to-present-at-neuroscience-2025-on-nov-15
Reviva To Present At Neuroscience 2025 On ...
11/12/2025 13:07:39

reviva-granted-european-patent-covering-use-of-brilaroxazine-in-treatment-of-pulmonary-fibrosis
Reviva Granted European Patent Covering Us...
11/10/2025 13:06:31

d-boral-capital-maintains-buy-on-reviva-pharmaceuticals-maintains-2-price-target
D. Boral Capital Maintains Buy on Reviva P...
10/28/2025 18:12:08

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $2 price target.

reviva-pharma-to-present-negative-symptom-data-for-brilaroxazine-in-schizophrenia-from-long-term-open-label-extension-trial-in-clinically-stable-schizophrenia-patients-at-cns-summit-2025
Reviva Pharma To Present Negative Symptom ...
10/28/2025 12:21:26

hc-wainwright--co-maintains-buy-on-reviva-pharmaceuticals-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on Reviv...
10/27/2025 10:35:51

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and lowers the ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/23/2025 17:07:13

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/14/2025 12:09:03

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/08/2025 17:06:09

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/06/2025 12:08:40

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
10/03/2025 21:05:59

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/03/2025 12:08:34

why-actelis-networks-shares-are-trading-higher-by-over-40-here-are-20-stocks-moving-premarket
Why Actelis Networks Shares Are Trading Hi...
10/03/2025 09:32:17

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 17:06:31

this-vse-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This VSE Analyst Begins Coverage On A Bull...
09/29/2025 11:35:20

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

chardan-capital-initiates-coverage-on-reviva-pharmaceuticals-with-buy-rating-announces-price-target-of-2
Chardan Capital Initiates Coverage On Revi...
09/29/2025 11:22:01

Chardan Capital analyst Rudy Li initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) with a Buy rating and announces ...

crude-oil-down-1-lennar-earnings-miss-views
Crude Oil Down 1%; Lennar Earnings Miss Views
09/19/2025 18:04:21

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/19/2025 17:06:19

nasdaq-gains-100-points-fedex-posts-upbeat-earnings
Nasdaq Gains 100 Points; FedEx Posts Upbea...
09/19/2025 14:16:28

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION